Breadcrumb Home Resources and Information Physicians and Scientists Resource Hub Response-adapted Dasatinib De-escalation Strategy Compared To Upfront Low-dose Dasatinib: A Prospective Cohort Study Response-adapted dasatinib de-escalation strategy compared to upfront Low-dose dasatinib: A prospective cohort study Leukemia Research , Mar 2026 Halder R et al. Leuk Res, June 2026 Link to full abstract Share Tweet Share Share